Market Overview:
The global implantable drug delivery systems market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in implantable drug delivery systems. Based on type, the global implantable drug delivery systems market is segmented into biodegradable and non-biodegradable implants. The biodegradable implants segment is expected to grow at a higher CAGR than the non-biodegradable implants segment during the forecast period. This growth can be attributed to factors such as increasing demand for minimally invasive surgeries and growing preference for bioabsorbables over non-bioabsorbables among surgeons. Based on application, the global implantable drug delivery systems market is divided into six segments: diabetic retinopathy, cardiovascular diseases, colorectal cancer, osteoporosis, ocular diseases (including age-related macular degeneration and glaucoma), and brain tumors. The diabetic retinopathy segment accounted for the largest share of this market in 2017 owing to high incidence rates of diabetes mellitus across geographies coupled with rising awareness about available treatment options among patients diagnosed with diabetes mellitus worldwide.
Product Definition:
An implantable drug delivery system is a device that can deliver medication to a specific location in the body. This type of system is often used to treat chronic conditions, such as diabetes or heart disease. The implantable drug delivery system can be either an injector or a pump.
Biodegradable:
Biodegradable is a material that can be broken down by biological processes, such as enzymes or bacteria. Some common examples of biodegradable materials are polymers, proteins, and lipids. Biodegradables have applications in various sectors including healthcare & pharmaceuticals and cosmetics industry. Pharmaceutical sector has been the major user of biodegradable materials for many years; currently there are more than 7500 registered products with therapeutic claims in the EU database (EMA).
Non-Biodegradable:
Non-biodegradable drug delivery systems are used to deliver the active pharmaceutical ingredient (API) in a controlled manner for a prolonged period. These non-biodegradable materials are widely used as implantable drug delivery systems owing to their several advantages such as they do not decompose, they offer protection against gastrointestinal and hepatic first pass metabolism, and they provide sustained release of API over an extended period.
Application Insights:
The other application segment includes the treatment of brain tumor, osteoporosis, diabetic retinopathy and cardiovascular diseases. The others segment held the largest market share in 2017 due to a high prevalence of these disorders. For instance, as per the WHO in 2018, over 300 million people are suffering from diabetes globally which is expected to increase to 400 million by 2030 if proper preventive measures are not taken. Therefore, demand for implantable drug delivery systems is expected to increase owing to this growing disease burden which will drive growth during the forecast period.
Diabetic retinopathy was one of the major segments that accounted for a significant market share in 2017 due largely to an increasing number of patients suffering from diabetes and an increasing prevalence rate worldwide.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing R&D investments by various companies and rising adoption of advanced technologies. In addition, high prevalence of chronic diseases such as osteoporosis, Alzheimer’s disease (AD), Parkinson's disease (PD) and other brain tumors are contributing toward regional growth.
Asia Pacific is anticipated to be the fastest-growing region over the forecast period owing to growing medical tourism industry in emerging countries such as India, China and Japan. Moreover, increasing healthcare expenditure by governments along with rising awareness about implantable drug delivery systems will drive growth during the estimated time span from 2018 to 2030 (USD X billion).
Growth Factors:
- Increasing prevalence of chronic diseases: The global implantable drug delivery systems market is expected to grow at a CAGR of over 9% during the forecast period owing to the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders.
- Technological advancements: The advent of novel technologies in implantable drug delivery systems is one of the key growth drivers for this market. These technologies include micro- and nano-drug delivery systems that offer better patient compliance and safety profiles.
- Rising demand for minimally invasive procedures: There is a growing demand for minimally invasive procedures across the globe, which is fueling the growth of implantable drug delivery systems market. These devices are less invasive as compared to traditional surgical methods and cause minimal damage to surrounding tissues. This helps in reducing postoperative complications and shortens hospital stay times.
Scope Of The Report
Report Attributes
Report Details
Report Title
Implantable Drug Delivery Systems Market Research Report
By Type
Biodegradable, Non-Biodegradable
By Application
Diabetic retinopathy, Cardiovascular diseases, Colorectal cancer, Osteoporosis, Ocular diseases, Brain tumors, Other
By Companies
Boston Scientific Corporation, Bayer Healthcare, Medtronic Inc., Allergan Inc., Abbott laboratories, Bausch and Lomb Inc., Genetech Inc., PSivda Corporation, Medtronic, Varian Medical System, Arrow International, Neurotech Pharmaceuticals, Replenish Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Implantable Drug Delivery Systems Market Report Segments:
The global Implantable Drug Delivery Systems market is segmented on the basis of:
Types
Biodegradable, Non-Biodegradable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diabetic retinopathy, Cardiovascular diseases, Colorectal cancer, Osteoporosis, Ocular diseases, Brain tumors, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific Corporation
- Bayer Healthcare
- Medtronic Inc.
- Allergan Inc.
- Abbott laboratories
- Bausch and Lomb Inc.
- Genetech Inc.
- PSivda Corporation
- Medtronic
- Varian Medical System
- Arrow International
- Neurotech Pharmaceuticals
- Replenish Inc.
Highlights of The Implantable Drug Delivery Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Biodegradable
- Non-Biodegradable
- By Application:
- Diabetic retinopathy
- Cardiovascular diseases
- Colorectal cancer
- Osteoporosis
- Ocular diseases
- Brain tumors
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Implantable Drug Delivery Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Implantable drug delivery systems are medical devices that are inserted into a patient's body to deliver medications. These devices can be placed under the skin, in the bladder, or in other areas of the body. They may include pumps, needles, and sensors that help administer medication accurately and quickly.
Some of the major players in the implantable drug delivery systems market are Boston Scientific Corporation, Bayer Healthcare, Medtronic Inc., Allergan Inc., Abbott laboratories, Bausch and Lomb Inc., Genetech Inc., PSivda Corporation, Medtronic, Varian Medical System, Arrow International, Neurotech Pharmaceuticals, Replenish Inc..
The implantable drug delivery systems market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Implantable Drug Delivery Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Implantable Drug Delivery Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Implantable Drug Delivery Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Implantable Drug Delivery Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Implantable Drug Delivery Systems Market Size & Forecast, 2020-2028
4.5.1 Implantable Drug Delivery Systems Market Size and Y-o-Y Growth
4.5.2 Implantable Drug Delivery Systems Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Biodegradable
5.2.2 Non-Biodegradable
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diabetic retinopathy
6.2.2 Cardiovascular diseases
6.2.3 Colorectal cancer
6.2.4 Osteoporosis
6.2.5 Ocular diseases
6.2.6 Brain tumors
6.2.7 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Implantable Drug Delivery Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Implantable Drug Delivery Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Biodegradable
9.6.2 Non-Biodegradable
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diabetic retinopathy
9.10.2 Cardiovascular diseases
9.10.3 Colorectal cancer
9.10.4 Osteoporosis
9.10.5 Ocular diseases
9.10.6 Brain tumors
9.10.7 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Biodegradable
10.6.2 Non-Biodegradable
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diabetic retinopathy
10.10.2 Cardiovascular diseases
10.10.3 Colorectal cancer
10.10.4 Osteoporosis
10.10.5 Ocular diseases
10.10.6 Brain tumors
10.10.7 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Biodegradable
11.6.2 Non-Biodegradable
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diabetic retinopathy
11.10.2 Cardiovascular diseases
11.10.3 Colorectal cancer
11.10.4 Osteoporosis
11.10.5 Ocular diseases
11.10.6 Brain tumors
11.10.7 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Biodegradable
12.6.2 Non-Biodegradable
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diabetic retinopathy
12.10.2 Cardiovascular diseases
12.10.3 Colorectal cancer
12.10.4 Osteoporosis
12.10.5 Ocular diseases
12.10.6 Brain tumors
12.10.7 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Biodegradable
13.6.2 Non-Biodegradable
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diabetic retinopathy
13.10.2 Cardiovascular diseases
13.10.3 Colorectal cancer
13.10.4 Osteoporosis
13.10.5 Ocular diseases
13.10.6 Brain tumors
13.10.7 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Implantable Drug Delivery Systems Market: Competitive Dashboard
14.2 Global Implantable Drug Delivery Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific Corporation
14.3.2 Bayer Healthcare
14.3.3 Medtronic Inc.
14.3.4 Allergan Inc.
14.3.5 Abbott laboratories
14.3.6 Bausch and Lomb Inc.
14.3.7 Genetech Inc.
14.3.8 PSivda Corporation
14.3.9 Medtronic
14.3.10 Varian Medical System
14.3.11 Arrow International
14.3.12 Neurotech Pharmaceuticals
14.3.13 Replenish Inc.
